Global dynamics of delayed HCV/HBV co-infection model with antibody immunity
Authors
A. M. Elaiw
- Department of Mathematics, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
A. D. Al Agha
- Department of Mathematical Science, College of Engineering, University of Business and Technology, Jeddah 21361, Saudi Arabia.
Gh. Alsaadi
- Department of Mathematics, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
A. D. Hobiny
- Department of Mathematics, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
Abstract
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infect liver cells (hepatocytes) and are responsible for most cases of chronic liver disease. HCV/HBV co-infected patients have a greater risk of severe liver disease, cirrhosis and liver cancer than mono-infected patients. In this paper, we develop a within-host HCV/HBV co-infection model with distributed delays and antibody immunity. The model involves nine delay differential equations (DDEs) that reflect the interactions between uninfected cells, latent HCV-infected cells, active HCV-infected cells, latent HBV-infected cells, active HBV-infected cells, free HCV particles, free HBV particles, HCV-specific antibodies, and HBV-specific antibodies. We test the nonnegativity and boundedness of the solutions. We compute all steady states and affirm the global stability. We confirm the results through numerical simulations. We found that time delays decrease the basic reproduction numbers leading to the stability of uninfected steady state. Also, fewer treatment efficacies will be required when employing a model with time delays. Moreover, increasing the stimulation rate of antibody immunity increases the densities of uninfected cells during co-infection.
Share and Cite
ISRP Style
A. M. Elaiw, A. D. Al Agha, Gh. Alsaadi, A. D. Hobiny, Global dynamics of delayed HCV/HBV co-infection model with antibody immunity, Journal of Mathematics and Computer Science, 39 (2025), no. 2, 192--232
AMA Style
Elaiw A. M., Al Agha A. D., Alsaadi Gh., Hobiny A. D., Global dynamics of delayed HCV/HBV co-infection model with antibody immunity. J Math Comput SCI-JM. (2025); 39(2):192--232
Chicago/Turabian Style
Elaiw, A. M., Al Agha, A. D., Alsaadi, Gh., Hobiny, A. D.. "Global dynamics of delayed HCV/HBV co-infection model with antibody immunity." Journal of Mathematics and Computer Science, 39, no. 2 (2025): 192--232
Keywords
- HCV
- HBV
- co-infection
- latent
- distributed
- delay
- antibody
- stability
MSC
References
-
[1]
A. D. Al Agha, A. M. Elaiw, Global dynamics of SARS-CoV-2/malaria model with antibody immune response, Math. Biosci. Eng., 19 (2022), 8380–8410
-
[2]
H. Alrabaiah, M. U. Rahman, I. Mahariq, S. Bushnaq, M. Arfan, Fractional order analysis of HBV and HCV co-infection under ABC derivative, Fractals, 30 (2022), 15 pages
-
[3]
M. Bachraoui, K. Hattaf, N. Yousfi, Qualitative analysis of a fractional model for HBV infection with capsids and adaptive immunity, Int. J. Dyn. Syst. Differ. Equ., 12 (2022), 146–162
-
[4]
H. Chen,W.Wang, R. Fu, J. Luo, Global analysis of a mathematical model on malaria with competitive strains and immune responses, Appl. Math. Comput., 259 (2015), 132–152
-
[5]
S. M. Ciupe, R. M. Ribeiro, A. S. Perelson, Antibody responses during hepatitis B viral infection, PLoS Comput. Biol., 10 (2014), 16 pages
-
[6]
H. Dahari, A. Lo, R. M. Ribeiro, A. S. Perelson, Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy, J. Theor. Biol., 247 (2007), 371–381
-
[7]
J. Danane, K. Allali, Z. Hammouch, Mathematical analysis of a fractional differential model of HBV infection with antibody immune response, Chaos Solitons Fractals, 136 (2020), 9 pages
-
[8]
A. M. Elaiw, A. D. Al Agha, Global dynamics of a general diffusive HBV infection model with capsids and adaptive immune response, Adv. Differ. Equ., 2019 (2019), 31 pages
-
[9]
A. M. Elaiw, A. D. Al Agha, Analysis of the in-host dynamics of tuberculosis and SARS-CoV-2 co-infection, Mathematics, 11 (2023), 1–24
-
[10]
A. M. Elaiw, A. D. Al Agha, S. A. Azoz, E. Ramadan, Global analysis of within-host SARS-CoV-2/HIV co-infection model with latency, Eur. Phys. J. Plus, 137 (2022), 1–22
-
[11]
A. M. Elaiw, A. D. Al Agha, G. Alsaadi, A. D. Hobiny, Global analysis of HCV/HBV codynamics model with antibody immunity, Eur. Phys. J. Plus, 139 (2024),
-
[12]
A. M. Elaiw, N. H. AlShamrani, Analysis of a within-host HIV/HTLV-I co-infection model with immunity, Virus Res., 295 (2021),
-
[13]
S. Foko, Dynamical analysis of a general delayed HBV infection model with capsids and adaptive immune response in presence of exposed infected hepatocytes, J. Math. Biol., 88 (2024), 55 pages
-
[14]
Y. Geng, J. Xu, J. Hou, Discretization and dynamic consistency of a delayed and diffusive viral infection model, Appl. Math. Comput., 316 (2018), 282–295
-
[15]
S. A. Gourley, Y. Kuang, J. D. Nagy, Dynamics of a delay differential equation model of hepatitis B virus infection, J. Biol. Dyn., 2 (2008), 140–153
-
[16]
J. K. Hale, S. M. Verduyn Lunel, Introduction to functional-differential equations, Springer-Verlag, New York (1993)
-
[17]
S. Harroudi, A. Meskaf, K. Allali, Modelling the adaptive immune response in HBV infection model with HBV DNAcontaining capsids, Differ. Equ. Dyn. Syst., 31 (2023), 371–393
-
[18]
K. Hattaf, A new class of generalized fractal and fractal-fractional derivatives with non-singular kernels, Fractals Fract., 7 (2023), 16 pages
-
[19]
K. Hattaf, A new mixed fractional derivative with applications in computational biology, Computation, 12 (2024), 17 pages
-
[20]
, Hepatitis, World Health Organization (WHO), (2022),
-
[21]
G. Huang, Y. Takeuchi, W. Ma, Lyapunov functionals for delay differential equations model of viral infections, SIAM J. Appl. Math., 70 (2010), 2693–2708
-
[22]
R. T. Ibarra, Treatment of HBV-HCV co-infection, Ann. Hepatol., 5 (2006), S49–S52
-
[23]
M. N. Jan, G. Zaman, N. Ali, I. Ahmad, Z. Shah, Optimal control application to the epidemiology of HBV and HCV co-infection, Int. J. Biomath., 15 (2022), 36 pages
-
[24]
H. K. Khalil, Nonlinear Systems, Prentice Hall, Upper Saddle River (2002)
-
[25]
K. Kitagawa, T. Kuniya, S. Nakaoka, Y. Asai, K. Watashi, S. Iwami, Mathematical analysis of a transformed ODE from a PDE multiscale model of hepatitis C virus infection, Bull. Math. Biol., 81 (2019), 1427–1441
-
[26]
D. Konstantinou, M. Deutsch, The spectrum of HBV/HCV co-infection: epidemiology, clinical characteristics, viral interactions and management, Ann. Gastroenterol., 28 (2015), 221–228
-
[27]
A. Korobeinikov, Global properties of basic virus dynamics models, Bull. Math. Biol., 66 (2004), 879–883
-
[28]
S. R. Lewin, R. M. Ribeiro, T. Walters, G. K. Lau, S. Bowden, S. Locarnini, A. S. Perelson, Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed, Hepatology, 34 (2001), 1012–1020
-
[29]
Z. Liu, J. Hou, Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection, Int. J. Med. Sci., 3 (2006), 57–62
-
[30]
K. Manna, Global properties of a HBV infection model with HBV DNA-containing capsids and CTL immune response, Int. J. Appl. Comput. Math., 3 (2017), 2323–2338
-
[31]
K. Manna, S. P. Chakrabarty, Chronic hepatitis B infection and HBV DNA-containing capsids: modeling and analysis, Commun. Nonlinear Sci. Numer. Simul., 22 (2015), 383–395
-
[32]
M. G. Mavilia, G. Y. Wu, HBV-HCV co-infection: viral interactions, management, and viral reactivation, J. Clin. Transl. Hepatol., 6 (2018), 296–305
-
[33]
Q. Maqsood, A. Sumrin, M. Iqbal, S. Younas, N. Hussain, M. Mahnoor, A. Wajid, Hepatitis C virus/hepatitis B virus co-infection: current prospectives, Antiviral Ther., 28 (2023), 1–18
-
[34]
K. G. Mekonen, S. F. Balcha, L. L. Obsu, A. Hassen, Mathematical modeling and analysis of TB and COVID-19 co-infection, J. Appl. Math., 2022 (2022), 20 pages
-
[35]
A. Meskaf, K. Allali, Y. Tabit, Optimal control of a delayed hepatitis B viral infection model with cytotoxic T-lymphocyte and antibody responses, Int. J. Dyn. Control, 5 (2017), 893–902
-
[36]
A. U. Neumann, N. P. Lam, H. Dahari, D. R. Gretch, T. E. Wiley, T. J. Layden, A. S. Perelson, Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy, Science, 282 (1998), 103–107
-
[37]
M. A. Nowak, C. R. M. Bangham, Population dynamics of immune responses to persistent viruses, Science, 272 (1996), 74–79
-
[38]
M. A. Nowak, S. Bonhoeffer, A. M. Hill, R. Boehme, H. C. Thomas, H. McDade, Viral dynamics in hepatitis B infection, Proc. Natl. Acad. Sci. U.S.A., 93 (1996), 4398–4402
-
[39]
M. A. Nowak, R. M. May, Virus Dynamics: Mathematical Principles of Immunology and Virology, Oxford University Press, Oxford (2000)
-
[40]
S. Pan, S. P. Chakrabarty, Threshold dynamics of HCV model with cell-to-cell transmission and a non-cytolytic cure in the presence of humoral immunity, Commun. Nonlinear Sci. Numer. Simul., 61 (2018), 180–197
-
[41]
S. Pan, S. P. Chakrabarty, Analysis of a reaction-diffusion HCV model with general cell-to-cell incidence function incorporating B cell activation and cure rate, Math. Comput. Simul., 193 (2022), 431–450
-
[42]
L. Pinky, H. M. Dobrovolny, SARS-CoV-2 co-infections: could influenza and the common cold be beneficial?, J. Med. Virol., (2020), 2623–2630
-
[43]
R. Qesmi, S. ElSaadany, J. M. Heffernan, J. Wu, A hepatitis B and C virus model with age since infection that exhibits backward bifurcation, SIAM J. Appl. Math., 71 (2011), 1509–1530
-
[44]
G. Raimondo, G. Cacciamo, C. Saitta, Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease?, Ann. Hepatol., 4 (2005), 100–106
-
[45]
J. Reyes-Silveyra, A. R. Mikler, Modeling immune response and its effect on infectious disease outbreak dynamics, Theor. Biol. Med. Model., 13 (2016), 1–21
-
[46]
F. A. Rihan, H. J. Alsakaji, Analysis of a stochastic HBV infection model with delayed immune response, Math. Biosci. Eng., 18 (2021), 5194–5220
-
[47]
F. A. Rihan, A. A. Arafa, R. Rakkiyappan, C. Rajivganthi, Y. Xu, Fractional-order delay differential equations for the dynamics of hepatitis C virus infection with IFN-α treatment, Alex. Eng. J., 60 (2021), 4761–4774
-
[48]
L. Rong, A. S. Perelson, Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents, Math. Biosci., 245 (2013), 22–30
-
[49]
M. Sadki, S. Harroudi, K. Allali, Local and global stability of an HCV viral dynamics model with two routes of infection and adaptive immunity, Comput. Methods Biomech. Biomed. Eng., 27 (2024), 1510–1537
-
[50]
W.-Y. Shen, Y.-M. Chu, M. ur. Rahman, I. Mahariq, A. Zeb, Mathematical analysis of HBV and HCV co-infection model under nonsingular fractional order derivative, Results Phys., 28 (2021), 1–7
-
[51]
Y.-F. Shih, C.-J. Liu, Hepatitis C virus and hepatitis B virus co-infection, Viruses, 12 (2020), 1–11
-
[52]
H. L. Smith, P. Waltman, The theory of the chemostat: dynamics of microbial competition, Cambridge University Press, (1995)
-
[53]
M. Tsiang, J. F. Rooney, J. J. Toole, C. S. Gibbs, Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy, Hepatology, 29 (1999), 1863–1869
-
[54]
W.Wang,W. Ma, Block effect on HCV infection by HMGB1 released from virus-infected cells: an insight from mathematical modeling, Commun. Nonlinear Sci. Numer. Simul., 59 (2018), 488–514
-
[55]
X. Wang, X. Meng, L. Rong, Global dynamics of a multiscale model for hepatitis C virus infection, Appl. Math. Lett., 149 (2024), 5 pages
-
[56]
G. J. M. Webster, S. Reignat, M. K. Maini, S. A. Whalley, G. S. Ogg, A. King, D. Brown, P. L. Amlot, R. Williams, D. Vergani, G. M. Dusheiko, A. Bertoletti, Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanism, Hepatology, 32 (2000), 1117–1124
-
[57]
D. Wodarz, Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses, J. Gen. Virol., 84 (2003), 1743–1750
-
[58]
D. Wodarz, Mathematical models of immune effector responses to viral infections: virus control versus the development of pathology, J. Comput. Appl. Math., 184 (2005), 301–319
-
[59]
D. Wodarz, R. M. May, M. A. Nowak, The role of antigen-independent persistence of memory cytotoxic T lymphocytes, Int. Immunol., 12 (2000), 467–477
-
[60]
R. Xu, Z. Ma, An HBV model with diffusion and time delay, J. Theor. Biol., 257 (2009), 499–509
-
[61]
X. Yang, Y. Su, H. Li, X. Zhuo, Optimal control of a cell-to-cell fractional-order model with periodic immune response for HCV, Symmetry, 13 (2021), 14 pages
-
[62]
N. Yousfi, K. Hattaf, A. Tridane, Modeling the adaptive immune response in HBV infection, J. Math. Biol., 63 (2011), 933–957
-
[63]
S. Zeinali, M. Shahrokhi, A. Pishro, Observer-based controller for treatment of hepatitis C infection using fractional order model, Math. Methods Appl. Sci., 45 (2022), 10689–10709
-
[64]
Z. Zhang, G. Liang, K. Chang, Stationary distribution of a reaction-diffusion hepatitis B virus infection model driven by the Ornstein-Uhlenbeck process, PLoS ONE, 18 (2023), 21 pages
-
[65]
H. Zhong, K. Wang, Dynamics on hepatitis B virus infection in vivo with interval delay, SIAM J. Appl. Dyn. Syst., 23 (2024), 205–235